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CHAPTER I 
INTRODUCTION 
The aim of this project was to investigate the 
possibility of utilizing the immune response of the 
host to inhibit and/or eliminate oral malignancy. Evi-
dence has shown that malignancies grow and spread often 
with relatively little, or no demonstrable response by 
the hosts immune system. These responses may be due to 
the tumor antigents lack of strength or inability of the 
host's innate immune system to recognize the tumor an-
tigen. Another possible concept is that the host's an-
tibodies may cover tumor antigens present on cell sur-
f aces thereby protecting the cancer cells from the cell 
mediated immune response. This would allow the cancer 
cells to proliferate and/or metastasize. 
In this study dimethylbenzanthracene, DMBA, was 
used to induce a carcinomatous lesion in the hamster 
cheek pouch. Dinitrochlorobenzene, DNCB, was employed 
to sensitize the buccal mucosa prior to, concomitantly 
with, or after tumor induction of the hamster cheek pouch 
in order to prevent, to eliminate or inhibit oral pouch 
tumor development. 
Leukoplakia has been recognized as the most common 
1 
pre-cancerous lesion of the mouth. The frequency of these 
premalignant to malignant changes in the oral epithelium 
can vary from 5 - 7% during an observation period of 3 -
20 years. The hamster cheek pouch model has been suc-
cessfully used to study this lesion. 
The induction of oral cancer in the pouch of the 
hamster may be achieved by painting the pouch with DMBA 
in mineral oil. 
The progress of this disease begins with erythe-
ma, and ulceration followed by repair. Increased mi-
totic activity, hyperkeratosis with acanthosis, papil-
loma and finally squamous cell carcinoma are the develop-
mental stages of the lesion. 
Practical clinical application of the results of 
this study could result in sensitizing human leukoplakias 
by topical application of DNCB or some other immune stim-
ulant. These drugs would immunotherapeutically eliminate 
the lesion rather than committing the lesion to surgery 
or risking a wait and watch policy. 
2 
CHAPTER II 
STATEMENT OF PROBLEM 
1. T~ determine the correct concentration of DNCB 
which will elicit an optimum cellular mediated response 
in the hamster cheek pouch. 
2. Can DNCB, applied to a hamster pouch mucosa, 
prevent the induction of tumors by DMBA? Specifically, 
can varying the time of application of DNCB during 
tumor induction modify the numbers or sizes of the 
tumors? 
3 
CHAPTER III 
REVIEW OF THE LITERATURE 
Since this project concerns itself with chemical 
carcinogens, a brief review of the literature concerning 
chemically induced tumors was necessary. 
Yamigiwa and Ichikawa (1915) induced epithelial 
malignancy in rabbit ears by cool tar application. 
Tsutsin, with a similar solution, produced cancer of the 
skin of mice. 
Carcinogenic polycyclic hydro-carbons were des-
cribed in the early 1930's by Kennaway and Huger. The 
first, discovered in 1930, was 1,2,5,6 dibenzanthra-
cene, and soon after 3,4-benzpyrene was isolated; 20 
methylcholanthrene, a very active carcinogen, was syn-
thesized from bile acids. 
Intensified studies have been done on these hy-
drocarbons; they have been called universal carcinogens 
because they produce neoplastic disease by topical ap-
plication, intramuscular and intravenous injection, or 
by simple feedings (Levy, 1963). 
Levy and Ring produced sarcomas in hamsters by 
subgingival implantation of crystalline 9,10-dimethyl-
l,2-benzanthracine. At four to five months, 80% of the 
4 
--
animals had tumors (cited by Salley, 1954). The effect 
of a single topical application of 9,10-dimethyl-l,2-
benzanthracine on the skin and mucous membrane of mouse 
lips was studied by Levy, Gorlin, and Gottzegen in 1950. 
After 35 days, some premalignant changes were noted on 
the labial mucous membrane. 
Wantland studied the effect of spraying and 
painting 20-methyl-cholanthrene, 1-2,5,6-dibenzanthra-
cene, and 2-acetylaminofluorine on the hamster cheek 
pouch. After six weeks there were no changes other 
than hyperplasia (Salley, 1954). 
Salley (1954) undertook an intensive study to 
determine the susceptibility of the hamster cheek pouch 
to carcinogen application, and to find the most suit-
able carcinogen for this purpose. Thirty-six three 
month old hamsters were used. The right pouch of each 
hamster was painted three times a week for sixteen weeks 
with a carcinogen with a #4 camel hair brush. An addi-
tional nine weeks of observation followed this period 
of painting. Three carcinogens were used in various 
combinations with two solvents. These potent carcino-
gens were chosen on the basis of studies by Berenblum 
and Iball (cited by Salley, 1954). The above informa-
tion is best shown in the following study (Page 6). 
Another group of animals was exposed to acetone 
5 
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CARCINOGEN-SOLVENT STUDY 
Series GrOUE_ Carcinogen Solvent No. Animals 
A. I. 9,10-dimethyl-l,2-
benzanthracene (DMBA) Acetone 3 Female 
3 Male 
II. 20-methylcholanthrene A·;etone 3 Female 
3 Male 
III. 3,4-benzpyrene Acetone 3 Female 
3 Male 
B. IV. 9,10-dimethyl-l,2-
benzanthracene Benzene 3 Female 
3 Male 
v. 20-methylcholanthrene Benzene 3 Female 
3 Male 
VI. 3,4-benypyrene Benzene 3 Female 
3 Male 
O'\ 
--
and benzine applications to determine the effects of the 
solvents listed in the preceding study. Another group 
was painted with physiologic saline to study any possible 
traumatic effects of the brushing. The animals were ex-
amined and weighed weekly. After sacrificing the ani-
mals with chloroform, whole pouches were dissected out 
and fixed with Bown's fluid. After dehydration and em-
bedding, several sections were cut and stained with hema-
toxylin and eosin and Mallory's connective tissue stain. 
Salley also sectioned cervical lymph nodes, tongue, 
palate, eosophagus, fore stomach, stomach, lungs, and 
liver. 
The first tissue changes were noted in the group 
using only benzene. Acute inflammation with necroses 
and sloughing were evident after two weeks. Adhesions 
had occurred in the pouch, reducing the normal three 
to three and one-half centimeters pouch to one and one-
half centimeters. In this same period of time, six 
hamsters of group B died; two hamsters of the benzene 
control group also died. Survivors of these groups 
healed with no recurrence of inflammation. 
Microscopic examination revealed four levels of 
change: 1) hyperplasia; 2) benign papilloma; 3) squa-
mous carcinoma in situ (pre-invasive); and 4) squamous 
cell carcinoma with local invasion and metastasis. The 
7 
, 
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following chart shows the results obtained (Page 9). 
There were six original animals in each series. 
Because of the high mortality rate, benzene proved un-
satisfactory. This is in agreement with Bradbury, Bachman, 
and Lewisohn. Bradbury, Bachman, Lewisohn, Stowal, and 
Cramer also found acetone very satisfactory as a solvent. 
It's free miscibility with water allows the carcinogen 
to be transported into the cell with ease (Salley, 1954). 
A glance at the following chart shows that 9,10-
dimethyl-l,2-benzanthracene (DMBA) in acetone is the 
most potent, effective carcinogen. Mineral oil replaced 
acetone as a more effective vehicle which will be cited 
further in this paper. Later, Morris (1961) tested the 
optimum concentrations of DMBA in the hamster pouch. 
He found that 1.5% solution was extremely toxic and caused 
a high percentage of mortality before initial lesions de-
veloped. Even the survivors required the same length of 
time to develop tumors as the 0.5% group. Morris found 
a 0.1% solution increased the latent period (period re-
quired to find some evidence of tumor), so that its use 
was not practical. Thus Morris found, as Salley did, that 
0.5% was an optimum concentration of DMBA for producing 
tumors. 
Morris (1961) also used this same carcinogen and 
painted animals both two and three times a week. Three 
r 
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ACETONE SERIES 
Number Time 
Number With Number Number of 
of Benign With With Onset 
Survivors Tumors Carcinoma Metastasis (Weeks) 
DMBA 5 0 5 5 7 
20-Methyl-
cholanthrene 5 2 2 0 25 
3,4-Benzpyrene 5 1 2 2 16 
BENZENE SERIES 
DMBA 4 0 3 3 8 
20-Methyl-
cholanthrene 3 1 0 0 25 
3,4-Benzpyrene 4 0 0 0 
\.0 
times a week was found most satisfactory, as Salley had 
previously determined~ A shorter latent period was found 
for the latter schedule. 
10 
Morris (1961) also studied the effect of age and 
sex on hamsters receiving DMBA applications to the pouch. 
Starting animals at three weeks, six weeks or. nine weeks 
of age made no difference in response to the carcinogen. 
Animals one year and a half, and older, phowed increased 
resistance to tumor induction. The sex of the specimen 
had no influence on the final results. In his experi-
ment, using 0.5% DMBA applied three times a week to the 
hamster pouch, Morris obtained tumors in most animals 
after 35 paintings or 12 weeks. Morris tested the various 
aspects of Salley's experiments and found a 0.5% carcino-
gen, concentration method of application, and a number 
of applications to be optimal for tumor production in the 
hamster cheek pouch. 
In another study, Salley (1955) improved his 
method for acquiring tumors in the hamster cheek pouch. 
The acetone solvent was replaced by a nonvolatile mineral 
oil (U.S.P. heavy) solvent. This modification of solvent 
decreased induction time with tri-weekly applications of 
DMBA from 6 to 7 weeks (with acetone as a solvent) to 
4 1/2 weeks. Fifty weeks of mineral oil paintings, per 
se, caused no carcinogenic activity. 
'··· .. :.-_: 
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Renstrup, et al. (1962) demonstrated that chronic 
mechanical irritation by use of producing ulceration in 
the cheek pouch of the hamster increases the onset of can-
cer induced by DMBA. 
Morris and Reisken {1965) showed that when the 
hamster cheek pouch was exposed to tri-weekly applications 
of DMBA for four weeks, all animals developed tumors in 
a minimum amount of time. Painting less frequently than 
three times a week, failed to produce tumors in all ani-
mals in twenty-one weeks. 
Elzay (1966) studied hamster pouches painted with 
DMBA in alcohol and noted that clinically they developed 
epithelial tumors earlier and larger than those painted 
with DMBA in mineral oil. 
Reisken and Berey (1968) showed that carcinomas 
induced in the pouches of eight to twelve week-old ham-
sters by DMBA differed in behavior according to the host 
strain. The mean latent period in inbred dark-eared par-
tial albino (DEA) hamsters was 7.3 weeks, compared to 
10.0 to 10.75 weeks in random-bred golden or cream ham-
sters. The average tumor growth rate was significantly 
higher in DEA animals than in the other two strains. 
Duncan (1969) studied the relation of certain 
hydrocarbons to metabolism and binding to cellular macro-
molecules. He found that the potent carcinogens were to 
12 
bind DNA and RNA ten times more readily than non-carcino-
gens. 
Immunotherapy 
The demonstration of tumor· specific antigens in 
human cancers was evidence that immunotherapy was an im-
portant mode of treatment. Evidence accumulated suggested 
that the cancer patient's immune response to these tumor 
specific antigens was important in controlling the de-
velopment and progression of their disease. Those pa-
tients who can demonstrate an active immune system have 
a better prognosis than those with general depression of 
their immune reactivity. These facts were cited by Hersh 
in 1971. 
Klein has shown that induction of delayed hyper-
sensitivity reaction at tumor sites resulted in selec-
tive reactions against premalignant and malignant epider-
mal lesions which led to their eradication (1969). 
Levis et al. showed 70% of basal cell carcinomas 
treated with DNCB underwent complete regression (1973). 
Klein believed the induction of delayed hypersen-
sitivity reactions in tumor nodules or tumor tissues re-
sulted in tumor regression in patients with basal or 
squamous cell carcinomas of the skin. Klein's initial 
immunotherapeutic approaches were introduced to patients 
with primary epidermal neoplasms. These neoplasms included 
13 
multiple, extensive, premalignant epidermal lesions such 
as keratosis of the surf ace epidermis and leukoplakia in-
volving mucous surfaces and mucocutaneous structures. 
Basal cell carcinomas, and squamous cell carcinomas, were 
also studied. 
The disappearance of locally invasive human cancer 
following therapeutic imposition of a controlled allergic 
contact dermatitis provided a useful model for the study 
of immunotherapy of cancer. This study applied the prin-
ciple of induced sensitivity and the induction of squa-
mous cell carcinoma as a model employing the hamster cheek 
pouch. 
\ 
CHAPTER IV 
MATERIALS AND METHODS 
A. Tumor Producing Agent 
The carcinogen chosen for this study was 9,10 di-
methyl i,2, benzanthracene (DMBA). 
This carcinqgen has been used by Salley and others to pro-
duce tumors in the hamster cheek pouch (Figure 1). A #4 
camel hair brush was used to paint a 0.5% solution of DMBA 
in heavy mineral oil into the cheek pouch. There is 15 mg. 
of DMBA in one application. 
Dinitrochlorobenzene (DNCD) 
14 
A yellow crystalline substance was used as a reagent for 
the detection and determination of nicotinic acid, nico-
tinamide and other pyridine compounds; a powerful skin 
irritant which resulted in a dermatitis. Two pellets of 
cotton containing the solution of DNCB were introduced 
deeply into the pouch and left to remain until expelled 
15 
by the hamster, usually after ten minutes. Each saturated 
pellet of cotton contained approximately one ml. of DNCB 
in acetone. 
c. Animals 
Thirty-seven three month-old dark-eared albino 
(DEA) hamsters were used. The animals were fed Purina 
rat chow and tap water. Animal immobilization was accom-
plished by grasping the animals in a gloved hand and ex-
posing the pouch by introducing a looped wire fastened 
to a stand, into the corner of the mouth (Figure 2). 
D. Cell Mediated Response Determination 
The objective was to.determine an optimum concen-
tration of DNCB which wouid elicit a cell mediated re-
sponse without injury to the animal or pouch mucosa as 
observed clinically. Concentrations of 0.1%, 0.5%, 1 5), 0' 
5% and 10% DNCB in reagent grade acetone were adminis-
tered to six hamsters. Two pellets of cotton, each con- .. 
taining 1 ml. of the various concentrations of DNCB were 
introduced deeply into each pouch and left to remain until 
expelled by the hamster, usually after ten minutes 
(Table I) • 
16 
Two hamsters received 0.1% solutions in their left 
pouch and 0.5% solutions in their right pouch. Two ham-
sters received 1% solutions in their left pouch and 5% so-
lutions in their right pouch. The last two hamsters re-
ceived a 10% solution in their left pouch and the right 
pouch was used as a control. Each hamster received the 
sensitizing doses on days one and three and the mucosa 
was challenged two weeks from the second sensitizing dose, 
or day seventeen. The challenging dose was one tenth the 
concentration of each of the initial sensitizing doses. 
One week of observation was allowed following the chal-
lenging dose for any reaction to occur. At this time 
the animals were sacrificed with a lethal dose of diethyl 
ether. 
This initial attempt failed in that the solutions 
proved to be too concentrated. One of the animals treated 
with 10% DNCB died before· the sacrifice day and others 
showed frank ulcerations through the pouches to the exter-
nal skin. Other pouches with the exception of the lowest 
concentrations showed large ulcerated areas (Figure 3). 
A second series of dilutions of DNCB was employed 
(Table II). The new range of solutions were 0.1%, 0.5%, 
.001%, .0005%, .00001%, .000005% of DNCB in acetone. The 
17 
control solution was composed of pure reagent acetone. The 
seven concentrations were administered to fourteen hamsters 
according to the following schedule. On the first and 
third days of the experiments, two hamsters received 0.1% 
DNCB in each of four pouches. The next two hamsters re-
ceived .05% DNCB in each of four pouches. The following 
two hamsters received a .001% DNCB in each of four pouches. 
The following two hamsters received a .0005% DNCB in each 
of four pouches. The following two hamsters received a 
.00001% DNCB in each of four pouches. The following two 
hamsters received a .000005% DNCB in each of four pouches. 
The last two hamsters served as controls and received only 
a solution of acetone in each of four pouches. The ham-
sters were then allowed to rest for fourteen days. At 
this time each hamster received the challenging doses of 
DNCB. One week of observation for adverse tissue reac-
tion was again allowed following the challenging dose. At 
this time the hamsters were sacrificed with a lethal dose 
of diethyl ether. 
The pouches were removed from the hamsters in all 
experimental groups, fixed in formation for twenty-four 
hours, washed in tap water and then they were processed to 
increasing concentrations of alcohol. The concentrations 
of alcohol were 65%, 70%, 80%, 95%, and 100%. The pouches 
were then transferred and cleared in xylene and then 
18 
embedded in liquid paraffin. Paraffin blocks were made 
and six micron sections were cut on a microtome and stained 
with hematoxylin and eosin. 
It was determined that the 0.1% concentration of 
DNCB produced an optimum cell response characterized by 
a lyrnphocytic infiltration in the lamina propria. This 
concentration was used to sensitize the mucosa in the fol-
lowing DNCB-DMBA hamster pouch tumor induction study. 
E. DNCB-DMBA Hamster Pouch Tumor Induction 
The following is a schedule employed using DNCB 
and DMBA in three separate experiments (Tables III A, B, 
and C) • 
Experiment I, Group A 
This experiment employed three hamsters. A 0.1% 
DNCB concentration in acetone with approximately 1 ml. of 
DNCB per pellet was administered to both pouches of three 
hamsters on day one and day three. Fourteen days later 
the pouches were challenged with a .01% DNCB concentration 
in acetone. On day eighteen twice weekly concentrations 
of 0.5% DMBA in mineral oil were administered by painting 
with a #4 camel hair brush with approximately 15 mg. of 
DMBA per application. The twice weekly painting continued 
for fourteen weeks at which time the animals were sacri-
ficed (Table III A) • 
--
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Experiment II, Groups B, E, F, G, H 
This experiment employed ten hamsters. A 0.1% DNCB 
concentration was administered to both pouches of ten ham-
sters on day one and day three and fourteen days later the 
pouches were challenged with a .01% DNCB concentration. On 
day eighteen twice weekly paintings of 0.5% DMBA in mineral 
oil were administered as in experiment I for fourteen 
weeks. At this time eight of the ten hamsters were re-
challenged with the .01% DNCB concentration; two hamsters 
not challenged with DNCB were used as controls. These two 
hamsters received only the DNCB and DMBA as in experiment 
I but no further challenge with DNCB. 
One week after the first rechallenge two hamsters 
were sacrificed. The remaining six hamsters again were 
rechallenged with a 0.01% DNCB solution applied to their 
pouches. One week later, two of the six remaining ham-
sters were sacrificed. The remaining four hamsters were 
again rechallenged with a 0.01% DNCB solution. One week 
later two of the four hamsters were sacrificed. The re-
maining two hamsters again were rechallenged with a 0.01% 
DNCB solution. In the next and final week the last two 
hamsters were sacrificed. Also, the two control hamsters 
were sacrificed at this time (Table III B). 
Experiment III, Groups c, D 
This experiment employed four hamsters. Unlike 
''\ 
experiment I and II, experiment III begins with first in-
ducing the tumor by twice weekly paintings with 0.5% DMBA 
in mineral oil for fourteen weeks. Then at this time, 
three hamsters were treated with the predetermined sensi-
tizing doses of 0.1% DNCB on day one, day three and a 
challenging dose of .01% DNCB fourteen days later. The 
three hamsters were then sacrificed. 
The fourth hamster was kept as a non-DNCB sensi-
tized control and received only DMBA paintings for four-
teen weeks and was then sacrificed. Note: no tumors 
were counted clinically before or after DNCB administra-
tion (Table III C). 
20 
The pouches were removed from all sacrificed ham-
sters, fixed tn formalin for twenty-four hours. They 
were dehydrated in ascending alcohols, cleared in xylene 
and embedded in paraffin. Sections were cut at six mi-
crons and stained with hematoxylin and eosin. The sec-
tions from all pouches were examined histologically and 
the tumors were counted and described. Measurements of 
the tumor dimensions as seen on the histologic slide were 
recorded. Al~o, using a reticular eyepiece containing a 
50 micron square grid, the number of lymphocytes and plas-
ma cells per fifty micron square field was averaged from 
three randomly selected fields and recorded. 
CHAPTER V 
RESULTS 
Experiment III, Group D (Table VI) 
This was the control group in which one hamster re-
ceived DMBA paintings only, for fourteen weeks. Two ad-
vanced squamous cell carcinomas were seen, one in each 
pouch (Figure 4). The two tumors measured 450 microns by 
250 microns and 400 microns by 300 microns, respectively. 
All the classical characteristics of malignancy were pres-
ent with hyperchromatism, frequent mitotic figures, cell 
nests and papillary projections. The cellular infiltrate 
in the connective tissue confronting the tumors was 
slight, an average of 12.2 lymphocytes per 50 microns 2 was 
seen and an average of 0.66 plasma cells was seen per 50 
. 2 
microns • 
Experiment III, Group C (Table VI) 
This group represents three animals treated first 
with DMBA and then treated with DNCB. Twelve non-invasive 
papillary tumors were seen (Figure 5). The size of the 
papillomas averaged 142 x 150 mm. apparently smaller than 
in the pouches in the Experiment III, Group D control. 
Four pouches were examined. Four tumors of the papilloma 
type were seen in one pouch, three tumors were observed in 
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a second and third pouch, and two tumors were seen in a 
fourth pouch. In this group the cellular infiltrate ex-
hibited an average of SO lymphocytes/SO microns 2 and 2.7 
plasma cells/SO microns 2 (Figure 6). The lymphocytes were 
seen invading the epithelium as well as the connective tis-
sue confronting the tumor. It was observed that some areas 
which were non-tumor bearing showed ulceration of the epi-
thelium and, also, exhibited a heavy infiltrate of lym-
phocytes into the lamina propria and epithelium (Figure 7). 
Polymorphonuclear leukocytes were also accompanying the 
lymphocytes and plasma cells {Figure 8) • 
Experiment I, Group A {Table IV) 
This group represents pretreatment with DNCB and 
then treatment with DMBA. A total of two non-invasive 
papillary tumors were found in four pouches. One tumor 
was a carcinoma in situ which showed hyperplasia with 
dyskeratosis, hyperchromatic cells, mitosis and acanthosis. 
The other tumor was a papillary carcinoma showing similar 
histologic characteristics. Also, the non-tumor areas of 
the pouch mucosa showed hyperkeratosis with acanthosis 
(Figures 9 and 10). The cellular infiltrate showed an 
average of 20 lymphocytes/SO microns 2 and .5 plasma cells/ 
50 microns 2 as seen under a high power field. This lympho-
cytic infiltrate was seen invading into the epithelium in 
ulcerated non-tumor bearing areas (Figure 11). 
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Experiment II, Groups B, E, F, G, H (Table V) 
This group represents animals pretreated with DNCB 
then treated with DMBA for fourteen weeks and then rechal-
lenged with DNCB. A total of five tumors of the papillary 
carcinoma type as seen before in the other experiments were 
found in twenty pouches. Seventeen pouches showed no tu-
mors. The tumors were papillary in nature and on the aver-
age measured 70 microns x 100 microns. A few areas of hy-
perkeratosis with acanthosis were seen with an infiltra-
tion of lymphocytes into the lamina propria and epithelium 
of non-tumor bearing areas (Figure 12). Two control ani-
mals in Group H showed two squamous cell carcinomas in si t:u 
measuring 300 microns x 400 microns. These animals re-
ceived initial DNCB treatment and subsequent DMBA adminis-
tration with no rechallenge of DNCB.~ 
CHAP'rER VI 
DISCUSSION 
The use of DNCB in hamster pouches to induce the 
cell mediated response is positively effective. However, 
high concentrations of DNCB is injurious to the pouches 
producing severe ulcerations. DNCB dilutions of 0.1% 
concentrations in acetone will induce an optimum cellular 
response without noticeable tissue modification to the ham-
ster pouch. The demonstrated cell mediated response cor-
responds well to studies undertaken by Klein and Holterman 
who showed induction of delayed hypersensitivity reactions 
at tumor sites resulted in reactions against epidermal le-
sions which led to their eradication. Also, Levis et al. 
showed basal cell carcinomas treated with DNCB underwent 
complete regression. This study showed a cell mediated 
response can be produced in the hamster pouch. Therefore, 
the concept that the hamster pouch is a privileged site, 
as reported by Shepro, cannot be supported by this study. 
Shepro ~ al. has pointed out the hamster pouch 
is an "immunologically privileged site". It therefore is 
pu~ported to possess poor immunological ability. This con-
ce~t was based on transplant studies in which skin grafts 
showed a long survival time in cheek pouch compared to 
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other parts of the body. A lack of lymphotic drainage has 
been reported to be the cause of the immunological privi-
leged site. However, Lindemann in 1968 did demonstrate the 
presence of lymphocytic vessels in the cheek pouch of the 
hamster. 
The hamster pouches develop tumors when treated 
with DNCB-DMBA. However, .hamster pouch tumor induction 
resulted in the greatest number of tumors when DMBA induc-
tion of tumors was followed by DNCB treatment. This was 
supported by the fact a total of twelve papilloma type 
non-invasive tumors were seen in four hamster pouches using 
this regimen. When sensitization with DNCB occurred be-
fore the induction of tumors by DMBA, only two non-invasive 
tumors were found in the four hamster pouches. This treat-
ment schedule using DNCB prior to DMBA tumor induction ap-
peared to be further effective when DNCB challenge of the 
mucosa bearing tumors was again employed. This became evi-
dent as only five non-invasive tumors were seen in twenty 
pouches. 
The hamster pouches treated with DMBA alone, showed 
two invasive type squamous cell carcinomas in two pouches. 
This would suggest DNCB did not alter tumor induction. 
However, it is apparent in the presence of a cell mediated 
response produced by DNCB administered either before or 
after DMBA, tumors will form. Treatment with DNCB prior to 
---
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DMBA showed reduced tumor numbers. It is significant that 
invasive tumors were seen only in the DMBA control animal 
while none was seen in the pouches treated with DNCB. 
All of the tumors found in the pouches treated with 
DNCB were of a smaller size than the tumors induced by DMBA 
alone. 
A lymphocytic and plasma cell mediated response was 
seen in all DNCB treated groups. In addition, the cell me-
diated response was greater than the pouches not treated 
with DNCB. In post-treated DNCB hamsters the cell mediated 
response was greatest with an average count per 50 microns 2 
in a high power field showing 50 lymphocytes and 2.7 plasma 
cells. This compares with the average count of 20 lympho-
cytes and .5 plasma cells in animals pretreated with DNCB. 
In the hamster given DMBA and not sensitized with DNCB, 
there also occurred a cell mediated response. The average 
count was 12.2 lymphocytes/SO microns 2 and .66 plasma cells/ 
r:o . 2 
.> microns . This suggested hamsters are capable of a cell 
mediated response without DNCB. Conversely, however, when 
DNCB treatment was employed the cell mediated response was 
clearly enhanced. 
An important observation is the presence of lym-
phocytes seen not only in the lamina propria, but also in-
vading the epithelium (Figure 7). It may be significant 
that the lymphocytes seen in the epithelium resulting from 
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a cell mediated response are reacting to some tumor asso-
ciated antigen. To be effective, these lymphocytes must 
contact the tumor cells in the epithelium to effect an an-
tigen-lymphocyte response. It was significant that a lym-
phocytic infiltrate was also observed in non-tumor bearing 
areas of DMBA-DN'...:B treated mucosa. In such areas micro-
ulcers were found. It is a possibility such ulcers may 
have resulted from a reaction between lymphocytes and epi-
thelial cells containing tumor associated antigens. Such 
cells may have been part of a preexisting tumor destroyed 
by the lymphocytes or a reaction with tumor associated an-
tigens on epithelial cells which have undergone neoplastic 
transformation. Furthermore, the ulcer may have been the 
result only of DNCB sensitized epithelial cells which were 
lost as a result of a cell mediated response which occurred 
upon challenge with DNCB. This suggestion was supported 
by the studies of Klein and Holterman and Levi who stated 
tumor progress may be altered by sensitizations and chal-
lenge with DNCB. Future studies with an increased number 
of specimens should be performed to validate the results 
of this pilot study. 
CHAPTER VII 
SUMMARY 
Thirty-seven three month-old dark-eared albino ham-
sters were used to determine the capacity of the hamster 
pouch to raise a cell mediated response. 
It also was the intent of the study to determine 
if DNCB sensitized mucosa either prevented tumor develop-
ment, reduced tumor number or destroyed the tumor. 
This investigation was divided into two sections. 
The first section was to determine the dilution of DNCB 
that could raise a cell mediated response without clini-
cally destroying the animal or mucosa. This was found to 
be 0.1% DNCB in acetone. 
The second section of the study consisted of three 
experiments. 
The first experiment employed three hamsters. The 
hamsters were pretreated with DNCB and then DMBA tumor in-
duction was initiated. 
The second experiment employed ten hamsters. The 
hamsters were pretreated with DNCB and then DMBA tumor ini-
tiation followed by weekly challenges with DNCB. 
The third experiment employed four hamsters. The 
hamsters were administered DNCB initially followed by DNCB 
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post-treatment. A control hamster received only DMBA. All 
DMBA applications were 0.5% in mineral oil. 
All of the animals treated with both DNCB and DMBA 
developed tumors. However, there was a reduction in tumor 
size and no tumor invasiveness seen in animals treated with 
DNCB when compared with animals not treated with DNCB. 
The pouch treated with DNCB showed a cell mediated 
response in all instances. This was noted whether or not 
a tumor was present. This demonstrated the capacity of 
DNCB to induce a cell mediated response. 
CHAPTER VIII 
CONCLUSION 
Tumors were induced in hamster pouches with DMBA 
alone or in combination with DNCB. 
The mucosa of the hamster was capable of producing 
a cell mediated response with a 0.1% DNCB concentration in 
acetone. 
There is suggestive evidence that the tumors in-
duced in hamster pouches are smaller in size when the 
pouches are treated with DNCB and DMBA than with DMBA 
alone. 
Hamster pouches which form tumors induced by DMBA 
alone showed a cell mediated response although the number 
of lymphocytes was less than when treated with DNCB. 
DNCB enhanced the cell mediated response in ham-
ster pouch tumors. 
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FIGURE 1 
DMBA INDUCED TUMOR IN HAMSTER CHEEK POUCH 
FIGURE 2 
EXPOSING HA...\1STER CHEEK POUCH BY INTRODUCTION 
OF LOOPED WIRE 
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FIGURE 3 
ULCERATED CHEEK POUCH TISSUE 
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FIGURE 4 
INVADING SQUAMOUS CELL CARCINOMA 
Epithelial pearls. Infiltratin g nests of squamous 
epithelial cells. X400 H.+E. 
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FIGURE 5 
PAPILLOMA 
XlOO H.+E. 
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FIGURE 6 
PAPILLOMA WITH LY.MPIIOCY'l'E INFILTRATION 
X250 H.+E. 
40 
X400 H.+E. 
X250 H.+E. 
FIGURE 7 
LYMPHOCYTES INVADING LAMINA PROPRIA IN ULCERATED AREA 
FIGURE 8 
LAMINA PROPRIA HAMSTER POUCH SHOWING CAPILLARY 
AND DEVELOPING PLASMA CELL 
ELECTRON MICROGRAPH 
Xl6800 
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FIGURE 9 
ACANTHOSIS WITH HYPERKERATOS I S AND 
LYMPHOCYTIC INFILTRATI ON 
X250 H.+E. 
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FIGURE 10 
THICKENED EP I THELIUM WITH KERATIN PEELING OFF 
X250 H.+E. 
44 
XlOO H.+E. 
FIGURE 11 
ULCERATION WITH LYMPHOCYTIC INFILTRATION 
45 
HYPERKERATOSIS WITH ACANTHOSlS 
X250 H.+E. 
HYPERKERATOSIS 
X400 H.+E. 
FIGURE 12 
46 
NORMAL HAMSTER POUCH EPITHELIUM 
XlOO H.+E. 
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TABLE I 
DNCB CELL MEDIATED RESPONSE DETERMINATION 
INITIAL SERIES 
DAY 1 AND DAY 3 SENSITIZING DOSE 
Hamster 0.1% 0.5% 1% 5% 
1 Left Pouch Right Pouch 
2 L.P. R.P. 
3 . L. p • R.P. 
4 L.P. R.P. 
5 
6 
Clinically Clinically ·Necrotic Necrotic 
Normal Normal 
10% 
L.P. 
L.P. 
Necrotic 
.i::. 
.....i 
~ 
Hamster .01% 
1 L.P. 
2 L.P. 
3 
4 
5 
6 
Clinically 
Normal 
TABLE I continued 
DAY 17 CHALLENGING DOSE 
.05% .1% 
R.P. 
R.P. 
L.P. 
L.P. 
Necrotic Necrotic 
0.5% 
R.P. 
R.P. 
Necrotic 
1% 
L.P. 
L.P. 
Animal 
Died 
.i::.. 
00 
..., 
TABLE II 
DNCB CELL MEDIATED RESPONSE.DETERMINATION 
Hamster 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
.000005% 
LP RP 
LP RP 
+ = Optimum Response 
SECOND SERIES 
DAY l AND DAY 3 APPLICATIONS 
.00001% 
LP RP 
LP RP 
.0005% 
LP RP 
LP RP 
.001% 
LP RP 
LP RP 
= Failure of Response 
o = Control 
LP = Left Pouch 
RP = Right Pouch 
.05% 
LP RP 
LP RP 
0.1% 
LP RP 
LP RP 
Acetone 
LP0 RPo 
LPo RPo 
.i:. 
l.O 
-~ 
TABLE II continued 
DAY 17 APPLICATION 
Hamster .0000005% .000001% .00005% .0001% 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
LP- RP-
LP- RP-
+ = Optimum Response 
LP- RP-
LP- RP-
= Failure of Response 
o = Control 
LP- RP-
LP- RP-
LP- RP-
LP- RP-
.005% 
LP- RP-
LP- RP-
f" 
.01% 
LP+ RP+ 
LP+ RP+ 
Acetone 
LPo RPo 
LPo RPo 
lJ1 
0 
-., 
Exp. I 
Group A 
Sensitization 
With DNCB 
Then DMBA 
(3 Animals) 
Day 1 
.1% 
DNCB 
Sensitizing 
Dose 
Tl\BLE III A 
FLOWSHEET OF DNCB-DMBA EXPERIMENTS 
Day 3 
.1% 
DNCB 
Sensitizing 
Dose 
Day 17 
.01% 
Challenging 
Dose 
Day 18 
DMBA Sacrifice 
Continue 
Biweekly 
Paintings 
For 
14 Weeks 
U'1 
..... 
-..., 
--------~--~==~~=~------~-~~ 
Exp. II 
Sensitization 
With DNCB 
Then DMBA 
and Subsequent 
Re challenge 
With DNCB 
(10 Ani.mals) 
Group B 
Group E 
Group F 
Group G 
Day 1 
.1% 
DNCB 
,. 
TABLE III B 
FLOWSHEET OF DNCB-DMBA EXPERIMENTS 
Day 3 Day 1 7 Day 18 
.1% • 01% DMBA. 
Continue Biweekly 
Paintings For 
14 Weeks 
Rechall. 
8 Animals 
.01% 
1 Week 
Sac. 2 An. 
Rechall. 6 An. 
1 Week 
Sac. 2 An. 
Rechall. 4 An. 
1 Week 
Sac. 2 An. 
Rechall. 2 An. 
1 Week 
Sac. 2 An. 
Last 
2 Animals 
Control 
(No Rechall.) 
Sacrifice 
2 Controls 
Group H U1 I\) 
~ 
Exp. III 
DMBA Tumor 
Production 
Then 
Sensitization 
With DNCB 
(4 Animals) 
TABLE III C 
FLOWSHEET OF DNCB-D.MBA EXPERIMENTS 
14 Weeks 
DMBA 
Biweekly 
3 Animals 
Day l 
.1% 
DNCB 
Day 3 
.1% 
DNCB 
Day 17 
.01% 
DNCB 
Sac. Group C 
~----------~------------,.-
~ ~ 
p 
1 Animal 
Control 
No DNCB 
Sac. Group D 
---- ' 
lJ1 
w 
Exp. I 
Treatment 
With DNCB 
Followed 
By DMBA 
Group A 
Pouch 1 
Pouch 2 
Pouch 3 
Pouch 4 
TABLE IV 
DNCB-DMBA EXPERIMENT 
None 
Squamous 
Tumor 
Size 
µ 
None 
Ca. In Situ 50 X 200 
None None 
Papilloma 40 x 120 
Other 
Epithelial 
Change 
1. Hyperplasia 
2. Hyperplasia 
With 
Dyskeratosis 
None 
" 
II 
Lymphocyte 
Count/SO µ2 
20 
" 
II 
II 
Plasma Cell 
Count/SO µ2 
• 5 
II 
" 
" 
01 
~ 
-, 
EXE· II 
Treatment With 
DNCB Followed 
By DMBA And 
Rechallenged 
With DNCB 
Tumor 
Group B Type 
Pouch 1 None 
Pouch 2 II 
Pouch 3 II 
Pouch 4 II 
TABLE V 
DNCB-DMBA EXPERIMENT 
Tumor Other 
Size Epithelial 
_µ_ Changes 
None Hyperplasia 
With 
Hyperkeratosis 
" None 
" 
II 
If II 
Lymphocyte 
Count/SO µ2 
20 
" 
II 
" 
Plasma Cell 
Count/50µ2 
.5 
" 
" 
II 
1.11 
1.11 
..., 
TABLE V continued 
Tumor Other 
Tumor Size Epithelial 
Grou~ Ty Ee µ Changes 
Pouch 1 None None Hyperplasia 
With 
Hyperkeratosis 
Pouch 2 II II None 
Pouch 3 II II II 
Pouch 4 Papilloma 50 x 100 II 
GrouE._.K 
Pouch 1 None None Hyperplasia 
With 
Hyperkeratosis 
Pouch 2 " " Hyperplasia 
Pouch 3 II II None 
Pouch 4 II II II 
Lymphocytes 
Count/50 µ2 
20 
II 
II 
II 
" 
II 
" 
II 
Plasma Cell 
Count/50 µ2 
.5 
II 
II 
II 
" 
" 
II 
II 
U1 
°' 
~ ---, 
-, 
TABLE V continued 
Tumor Other 
Tumor Size Epithelial Lymphocyte Plasma Cell 
GrouI?....Q Type µ Changes Co't1n t/50 µ 2 Count/SO µ2 
Pouch 1 None None Hyperplasia 20 .5 
Pouch 2 Papilloma 100 X 175 None II " 
Pouch 3 None None II II " 
Pouch 4 II II II II " 
GrouE....!:!. 
Pouch 1 Squamous 300 X 400 Hyperplasia II " 
Cell Ca. 
In Situ 
---
Squamous 300 X 400 Hyperplasia II " 
Cell Ca. 
In Situ 
---
Pouch 2 None None None " " 
Pouch 3 II II Hyperplasia II II 
Pouch 4 II II None 
U'1 
.....i 
Exp. III 
DMBA Tumor 
Production 
Then DNCB 
Treatment 
Group C 
Pouch 1 
Pouch 2 
Tumor 
~ 
Papilloma 
II 
II 
II 
II 
II 
II 
TABLE VI 
DNCB-DMBA EXPERIMENT 
Tumor Other 
Size Epithelial 
µ Changes 
135 x 135 Ulcer 
40 x 80 II 
60 x 60 None 
60 x 60 II 
135 x 150 Ulcer 
110 x 110 None 
150 x 200 II 
Lympohcyte 
co·unt/50 µ2 
50 
" 
II 
II 
" 
II 
II 
Plasma Cell 
Count/SO ·µ2 
2.7 
II 
II 
II 
II 
II 
II 
(Jl 
co 
--, 
TABLE VI continued 
Tumor Other 
Tumor Size Epithelial 
~ )l Changes 
Pouch 3 Papilloma 100 x 150 Hyperplasia 
Papilloma 300 x 200 None 
Or Carcinoma 
In Situ 
---
Papilloma 150 x 75 II 
Pouch 4 II so x 50 Hyperplasia 
II 50 x 80 None 
Grou12 D 
(Control) 
Pouch 1 Invasive 450 x 250 None 
Carcinoma 
Pouch 2 Invasive 400 x 300 " 
Carcinoma 
Lymphocyte 
Count/50 µ2 
50 
" 
" 
II 
II 
12.2 
II 
Plasma Cell 
Count/50 µ2 
2.7 
II 
II 
" 
II 
.66 
" 
Ul 
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